Home
News
Interviews
Companies
Videos
Subscribe
The
Latest
The Latest
News
Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023
News
Cybin Announces Streamlined Clinical Alignment
News
Numinus Expands Research Capabilities with new Phoenix Clinical Research Site
News
Wellbeing Provides Bi-Weekly Default Status Report
More Articles
FEATURED
Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
News
Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout
News
Awakn Life Sciences Signs Its First Licensing Partnership Agreement in Europe
Trending
#
News
PharmaDrug Collaborates with PharmaTher for Development of DMT Transdermal Patch
#
News
Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
#
News
Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023
#
News
Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia
#
News
Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery
Companies
#
ATAI Life Sciences
NEO
NASDAQ
ATAI
CSE
TSXV
Private Company
Non-Profit
#
Compass Pathways
NEO
NASDAQ
CMPS
CSE
TSXV
Private Company
Non-Profit
#
Algernon Pharmaceuticals
NEO
NASDAQ
CSE
AGN
TSXV
Private Company
Non-Profit
#
Mind Medicine (MindMed)
NEO
MMED
NASDAQ
MNMD
CSE
TSXV
Private Company
Non-Profit
#
Cybin Inc.
NEO
CYBN
NASDAQ
CSE
TSXV
Private Company
Non-Profit
